Nyree Crawford

1.7k total citations
34 papers, 1.2k citations indexed

About

Nyree Crawford is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Nyree Crawford has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Nyree Crawford's work include Cell death mechanisms and regulation (15 papers), Ubiquitin and proteasome pathways (6 papers) and Cancer-related Molecular Pathways (4 papers). Nyree Crawford is often cited by papers focused on Cell death mechanisms and regulation (15 papers), Ubiquitin and proteasome pathways (6 papers) and Cancer-related Molecular Pathways (4 papers). Nyree Crawford collaborates with scholars based in United Kingdom, Ireland and United States. Nyree Crawford's co-authors include Daniel B. Longley, Jamie Z. Roberts, Paul B. Mullan, D. Paul Harkin, Niamh E. Buckley, Patrick G. Johnston, Richard D. Kennedy, Julia J. Gorski, Zenobia D’Costa and Kienan I. Savage and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and PLoS ONE.

In The Last Decade

Nyree Crawford

33 papers receiving 1.2k citations

Peers

Countries citing papers authored by Nyree Crawford

Since Specialization

Citations

This map shows the geographic impact of Nyree Crawford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nyree Crawford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nyree Crawford more than expected).

Fields of papers citing papers by Nyree Crawford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nyree Crawford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nyree Crawford. The network helps show where Nyree Crawford may publish in the future.

Co-authorship network of co-authors of Nyree Crawford

This figure shows the co-authorship network connecting the top 25 collaborators of Nyree Crawford. A scholar is included among the top collaborators of Nyree Crawford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nyree Crawford. Nyree Crawford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGF 2024 ·Clinical and Translational Medicine ·(unknown), (unknown), Mark Wappett, Julien Daubriac, Ian Lobb, (unknown), Nyree Crawford, Natalie Page, (unknown), (unknown), (unknown), Matthew Helm, C. O'Dowd, Richard D. Kennedy, Gérald Gavory, Aaron Cranston, Daniel B. Longley, Xavier Jacq, Timothy Harrison	9
2	TNF-α synergises with IFN-γ to induce caspase-8-JAK1/2-STAT1-dependent death of intestinal epithelial cells 2021 ·Cell Death and Disease ·Jerzy A. Woznicki, (unknown), Peter F. Flood, (unknown), Ciaran M. Lee, Panagiota Stamou, (unknown), (unknown), Karine Regazzoni, Nyree Crawford, Simon S. McDade, Daniel B. Longley, Pedro Aza‐Blanc, Fergus Shanahan, (unknown), Jane McCarthy, Silvia Melgar, Bradford L. McRae, Kenneth Nally	109
3	Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer 2021 ·Molecular Cancer Therapeutics ·Nyree Crawford, (unknown), Tamas Sessler, Christopher McCann, (unknown), (unknown), (unknown), (unknown), Joanne M. Munck, Tomoko Smyth, (unknown), Vanessa Martins, Mark Lawler, Philip D. Dunne, Emma Kerr, Simon S. McDade, Vicky M. Coyle, Daniel B. Longley	21
4	Patients with mesenchymal tumours and high Fusobacteriales prevalence have worse prognosis in colorectal cancer (CRC) 2021 ·Gut ·Manuela Salvucci, Nyree Crawford, (unknown), Susan Bullman, Daniel B. Longley, Jochen H.M. Prehn	30
5	The role of Ubiquitination in Apoptosis and Necroptosis 2021 ·Cell Death and Differentiation ·Jamie Z. Roberts, Nyree Crawford, Daniel B. Longley	142
6	Molecular subtype-specific responses of colon cancer cells to the SMAC mimetic Birinapant 2020 ·Cell Death and Disease ·Michael Fichtner, Emir Bozkurt, Manuela Salvucci, Christopher McCann, Katherine McAllister, (unknown), Heiko Düßmann, Sinéad Kinsella, Nyree Crawford, Tamas Sessler, Daniel B. Longley, Jochen H.M. Prehn	19
7	Fusobacterium nucleatum in the Colorectum and Its Association with Cancer Risk and Survival: A Systematic Review and Meta-analysis 2020 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), Helen G. Coleman, (unknown), Daniel B. Longley, Nyree Crawford, Liam Murray, Andrew T. Kunzmann	93
8	Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancer 2020 ·Cell Death Discovery ·Jennifer S. Ferris, Margarita Espona‐Fiedler, (unknown), Caitriona Holohan, Nyree Crawford, (unknown), Jamie Z. Roberts, Mark Wappett, Simon S. McDade, Daniel B. Longley, Victoria Coyle	23
9	DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo models 2020 ·Journal of Controlled Release ·(unknown), (unknown), Kelly M. Redmond, Peter Smyth, Michelle K. Greene, (unknown), (unknown), Nyree Crawford, (unknown), (unknown), (unknown), Sandra Roche, Martin Clynes, Robert M. Straubinger, Daniel B. Longley, Christopher J. Scott	20
10	A revised model of TRAIL ‐R2 DISC assembly explains how FLIP (L) can inhibit or promote apoptosis 2020 ·EMBO Reports ·(unknown), (unknown), Catherine Higgins, Joanna Majkut, Tamas Sessler, Kirsty M. McLaughlin, Christopher McCann, Jamie Z. Roberts, Nyree Crawford, Simon S. McDade, Christopher J. Scott, Timothy Harrison, Daniel B. Longley	40
11	Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonists 2018 ·Cell Death and Disease ·Christopher McCann, Nyree Crawford, Joanna Majkut, Caitriona Holohan, (unknown), Pamela Maxwell, Chee Wee Ong, Melissa J. LaBonte, Simon S. McDade, David Waugh, Daniel B. Longley	12
12	FLIP: A Targetable Mediator of Resistance to Radiation in Non–Small Cell Lung Cancer 2016 ·Molecular Cancer Therapeutics ·(unknown), (unknown), Conor A. Bradley, (unknown), (unknown), (unknown), Joanna Majkut, Catherine Higgins, Nyree Crawford, Caitriona Holohan, Patrick G. Johnston, Timothy Harrison, Gerard G. Hanna, Karl T. Butterworth, Kevin M. Prise, Daniel B. Longley	19
13	HDAC Inhibition Overcomes Acute Resistance to MEK Inhibition in BRAF -Mutant Colorectal Cancer by Downregulation of c-FLIPL 2015 ·Clinical Cancer Research ·(unknown), (unknown), (unknown), (unknown), Nyree Crawford, Lucía Pérez–Carbonell, Mark Lawler, Daniel B. Longley, Patrick G. Johnston, Sandra Van Schaeybroeck	55
14	Differential affinity of FLIP and procaspase 8 for FADD’s DED binding surfaces regulates DISC assembly 2014 ·Nature Communications ·Joanna Majkut, Miriam Sgobba, Caitriona Holohan, Nyree Crawford, (unknown), Emma Kerr, Catherine Higgins, Keara L. Redmond, Joel S. Riley, (unknown), Dean A. Fennell, Sandra Van Schaeybroeck, Shozeb Haider, Patrick G. Johnston, David Haigh, Daniel B. Longley	64
15	Prognostic and therapeutic relevance of FLIP and procaspase-8 overexpression in non-small cell lung cancer 2013 ·Cell Death and Disease ·Joel S. Riley, Ryan Hutchinson, Darragh G. McArt, Nyree Crawford, Caitriona Holohan, (unknown), Sandra Van Schaeybroeck, Manuel Salto‐Tellez, P. G. Johnston, Dean A. Fennell, Kathy Gately, Kenneth J. O’Byrne, Robert Cummins, E. Kay, Peter Hamilton, (unknown), DB Longley	1
16	SAHA overcomes FLIP-mediated inhibition of SMAC mimetic-induced apoptosis in mesothelioma 2013 ·Cell Death and Disease ·Nyree Crawford, (unknown), Caitriona Holohan, Joanna Majkut, Michael McGrath, Patrick G. Johnston, Gianni Chessari, George A. Ward, David Waugh, Dean A. Fennell, Daniel B. Longley	31
17	The ΔNp63 Proteins Are Key Allies of BRCA1 in the Prevention of Basal-Like Breast Cancer 2011 ·Cancer Research ·Niamh E. Buckley, (unknown), Karin Jirström, Elaine W. Kay, Nyree Crawford, Anthony O’Grady, Katherine M. Sheehan, (unknown), Ching‐Wei Wang, Dennis J. McCance, Patrick G. Johnston, Richard D. Kennedy, D. Paul Harkin, Paul B. Mullan	34
18	T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells 2010 ·Oncogene ·Keara L. Redmond, Nyree Crawford, Hannah Farmer, Zenobia D’Costa, (unknown), Niamh E. Buckley, Richard D. Kennedy, Patrick G. Johnston, D. Paul Harkin, Paul B. Mullan	60
19	Dynamical Systems Analysis of Mitochondrial BAK Activation Kinetics Predicts Resistance to BH3 Domains 2008 ·PLoS ONE ·(unknown), Nyree Crawford, (unknown), Patrick G. Johnston, (unknown), Dean A. Fennell	14
20	Machine vision based stochastic analysis of cancer cell mitochondrial dysfunction induced by a BH3 domain 2008 ·APOPTOSIS ·(unknown), Nyree Crawford, Patrick G. Johnston, Dean A. Fennell	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact